Skip to content

奥瑞克制药

US · ORIC #3089 按市值排名 上市于 2020
12.35 -0.42 -3.29%
实时 - 追踪5344个代码 - 心跳于494秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期(2026/Q3)披露持股的机构数量减少了1家。
  • 机构持股总比例下降了2.7个百分点。

机构持股

机构持股比例
120.01% -2.68pp
机构数量
207 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund42.60%
Hedge Fund38.73%
VC/PE Fund31.52%
Public Company4.97%
Individual/Insider1.04%
Family Office/Trust0.99%
Private Company0.93%
Government Pension Fund0.16%

主要股东 截至 2026-06-30

Nextech Invest Ltd. 6.91% · 7.16M 股
BlackRock 6.58% · 6.82M 股
EcoR1 Capital, LLC 6.49% · 6.73M 股
T. Rowe Price Group, Inc. 6.38% · 6.62M 股
Viking Global Investors LP 4.95% · 5.13M 股
State Street Global Advisors 4.72% · 4.89M 股
SR One Capital Management, LP 4.45% · 4.62M 股
Vanguard Capital Management, LLC 4.36% · 4.52M 股
VR Management, LLC 4.17% · 4.32M 股
New Enterprise Associates, Inc. 3.97% · 4.12M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 24次买入 · 26次卖出

姓名职务持股比例
Jacob Chacko Chief Executive Officer 0.56%
Richard Heyman Co-Founder, Independent Chairman & Member of Scientific Advisory Board 0.24%
Lori Kunkel Independent Director 0.08%
Dominic Piscitelli Chief Financial Officer 0.07%
Pratik Multani Chief Medical Officer 0.07%
Angie You Independent Director 0.03%
Mardi Dier Independent Director --
Steven Hoerter Indepdnent Director --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-30 Richard Heyman Co-Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -3,200 $12.91
2026-09-30 Richard Heyman Co-Founder, Independent Chairman & Member of Scientific Advisory Board Derivative Exercise and Sale -3,500 $1.60–12.91
2026-09-27 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -13,400 $4.36–13.53
2026-09-23 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -600 $4.36–13.51
2026-08-25 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -77,000 $4.36–13.69
2026-07-23 Richard Heyman Co-Founder, Independent Chairman & Member of Scientific Advisory Board Open Market Disposition -9,600 $12.02
2026-07-23 Richard Heyman Co-Founder, Independent Chairman & Member of Scientific Advisory Board Derivative Exercise and Sale -3,500 $1.60–12.02
2026-07-05 Richard Heyman Co-Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -300 $12.00
2026-02-23 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -52,000 $4.36–13.51
2026-01-15 Richard Heyman Co-Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -6,700 $12.00
2026-01-01 Pratik Multani Chief Medical Officer Other Derivative Acquisition +35,500 --
2026-01-01 Pratik Multani Chief Medical Officer Other Derivative Acquisition +214,000 $8.17
2026-01-01 Angie You Independent Director Other Derivative Acquisition +40,000 $8.17
2026-01-01 Richard Heyman Co-Founder, Independent Chairman & Member of Scientific Advisory Board Other Derivative Acquisition +40,000 $8.17
2026-01-01 Lori Kunkel Independent Director Other Derivative Acquisition +40,000 $8.17
2026-01-01 Mardi Dier Independent Director Other Derivative Acquisition +40,000 $8.17
2026-01-01 Jacob Chacko Chief Executive Officer Other Derivative Acquisition +112,500 --
2026-01-01 Jacob Chacko Chief Executive Officer Other Derivative Acquisition +675,000 $8.17
2026-01-01 Steven Hoerter Indepdnent Director Other Derivative Acquisition +40,000 $8.17
2026-01-01 Dominic Piscitelli Chief Financial Officer Other Derivative Acquisition +34,500 --

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

奥瑞克制药 讨论区 0 条评论

发表评论